ONE-WAYOngoing theme · still written in the latest filings
Entry into the nucleic acid drug raw material CDMO business based on diagnostic oligonucleotides
An initiative to enter the CDMO business for oligonucleotides used as raw materials for nucleic acid drugs, leveraging the technology and manufacturing platform for diagnostic oligonucleotides following the launch of Bio Park operations.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.